NCT05601557
Not yet recruiting
Not Applicable
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver Disease
Sujun Zheng0 sites480 target enrollmentDecember 1, 2022
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diagnosis ， Treatment， Genetic and Metabolic Liver Disease
- Sponsor
- Sujun Zheng
- Enrollment
- 480
- Primary Endpoint
- death
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
- Establish a follow-up cohort of genetic and metabolic liver disease in The Chinese population, and carry out research on disease spectrum, clinical characteristics and personalized diagnosis and treatment to improve the level of diagnosis and treatment.
- Establish a multidisciplinary collaborative diagnosis and treatment model of genetic metabolic liver disease, develop and promote diagnosis and treatment paths, and improve the diagnosis and treatment ability of genetic metabolic liver disease in Beijing and even the whole country.
- Establish a new CRISPR gene diagnosis technology to realize fast and low-cost genetic testing.
- Elucidating the genetic mutation spectrum of common genetic and metabolic liver disease in China is helpful to accurate gene diagnosis and functional research.
- Study the genotype-phenotype, mutation and clinical outcome relationship and influencing factors of the common genetic and metabolic liver disease population in China, to guide the early diagnosis, early treatment and improve the prognosis.
Investigators
Sujun Zheng
Ethics Committee Member
Beijing YouAn Hospital
Eligibility Criteria
Inclusion Criteria
- •Meet the diagnostic criteria of each disease.
Exclusion Criteria
- •Co-infected with hepatitis B virus, hepatitis C virus and HIV;
- •Patients with liver fibrosis and cirrhosis caused by other causes;
- •Patients with alcoholic liver disease and autoimmune liver disease;
- •Liver malignancy has been suggested or confirmed by evidence;
- •Combined with other serious systemic diseases.
Outcomes
Primary Outcomes
death
Time Frame: 5 years
Death during the study was the outcome event
Similar Trials
Completed
Not Applicable
Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLDHealthyNCT04494360Janssen Research & Development, LLC830
Completed
Not Applicable
To Study the Effects of Host Genetic Factors on Liver CirrhosisLiver CirrhosisNCT05095181Asfendiyarov Kazakh National Medical University1,000
Recruiting
Not Applicable
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesNAFLD - Nonalcoholic Fatty Liver DiseaseDiabetesObesityMetabolic SyndromeCirrhosisLiver CancerNASH - Nonalcoholic SteatohepatitisHCC - Hepatocellular CarcinomaFatty LiverNCT04371042Fondazione Policlinico Universitario Agostino Gemelli IRCCS5,000
Unknown
Not Applicable
Biochemical and Genetic Markers in Liver DiseasesBiochemical and Genetic Markers in Liver DiseasesNCT01706614University Hospital Heidelberg500
Unknown
Not Applicable
Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisCarcinoma, HepatocellularNCT03083002University of Modena and Reggio Emilia250